HomeBiogas Statistics

Total Valuation

HomeBiogas has a market cap or net worth of ILS 28.52 million. The enterprise value is 19.90 million.

Market Cap	28.52M
Enterprise Value	19.90M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

HomeBiogas has 24.13 million shares outstanding. The number of shares has increased by 5.66% in one year.

Current Share Class	24.13M
Shares Outstanding	24.13M
Shares Change (YoY)	+5.66%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	9.49%
Owned by Institutions (%)	21.06%
Float	13.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.98
PB Ratio	1.57
P/TBV Ratio	1.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.58
EV / Sales	2.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.17

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.09.

Current Ratio	2.36
Quick Ratio	1.56
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -99.03% and return on invested capital (ROIC) is -46.76%.

Return on Equity (ROE)	-99.03%
Return on Assets (ROA)	-36.28%
Return on Invested Capital (ROIC)	-46.76%
Return on Capital Employed (ROCE)	-139.46%
Revenue Per Employee	118,262
Profits Per Employee	-423,541
Employee Count	81
Asset Turnover	0.19
Inventory Turnover	1.98

Taxes

In the past 12 months, HomeBiogas has paid 18,212 in taxes.

Income Tax	18,212
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.49% in the last 52 weeks. The beta is -0.02, so HomeBiogas's price volatility has been lower than the market average.

Beta (5Y)	-0.02
52-Week Price Change	-43.49%
50-Day Moving Average	130.30
200-Day Moving Average	131.79
Relative Strength Index (RSI)	38.90
Average Volume (20 Days)	61,057

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HomeBiogas had revenue of ILS 9.58 million and -34.31 million in losses. Loss per share was -1.43.

Revenue	9.58M
Gross Profit	651,972
Operating Income	-29.22M
Pretax Income	-34.29M
Net Income	-34.31M
EBITDA	-28.13M
EBIT	-29.22M
Loss Per Share	-1.43

Full Income Statement

Balance Sheet

The company has 10.33 million in cash and 1.71 million in debt, giving a net cash position of 8.62 million or 0.36 per share.

Cash & Cash Equivalents	10.33M
Total Debt	1.71M
Net Cash	8.62M
Net Cash Per Share	0.36
Equity (Book Value)	18.16M
Book Value Per Share	0.75
Working Capital	12.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.44 million and capital expenditures -630,118, giving a free cash flow of -17.07 million.

Operating Cash Flow	-16.44M
Capital Expenditures	-630,118
Free Cash Flow	-17.07M
FCF Per Share	-0.71

Full Cash Flow Statement

Margins

Gross Margin	6.81%
Operating Margin	-305.02%
Pretax Margin	-357.95%
Profit Margin	n/a
EBITDA Margin	-293.69%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HomeBiogas does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.66%
Shareholder Yield	n/a
Earnings Yield	-120.30%
FCF Yield	-59.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HomeBiogas has an Altman Z-Score of -9.45 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.45
Piotroski F-Score	1